Yuani Uppal

PHD Doctor of Philosophy,  Massachusetts General Hospital 

Location: India

Consulting Services

Biostatistics Data Science-Bioinformatics Scientific Writing Research Consulting Legal Support

Areas Of Interest

Induced Labor Calcium Calmodulin Dependent Protein Kinases, Restricted SNAP Programs Phospholipase C-beta4 Domain, MYND EPN-300 Musculo-Aponeurotic Systems, Superficial Spemann Organizer Disease, Morquio A Oxidoreductases Acting on CH-CH Group Donors Receptors, Pituitary Hormone Releasing Hormone Compounds, Biphenyl BMS-232632-05 Mitogen-Activated Protein Kinase Kinase 1 Chinese Rhubarb Enteritides, Mink Viral Donation, Embryo Receptor, Dopamine D1B Primitive Neuroepithelial Neoplasm Cornelia de Lange Syndrome 1 Antagonists, Histamine H3 Rhesus Macaque Cytokeratin 18 n-Hexadecane Polyoxyethylene Glycol Monether Ruptures, Gastric Power Supplies

Professional Narrative

Dr. Yuani Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Director Medicine, Harvard Med 2010
Medical Writer, Harvard Med 2009

Education

Director Medicine, Weill Medical College 1996
Doctor of osteopathic medicine, Weill Medical College 2000

Referees


Publications

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :